Nephrotic Syndrome + Glomerulonephritis Flashcards
Proteinuria
Represents abnormal glomerular filtration barrier function (as this is what is supposed to keep proteins out of urine)
Normal proteinuria
<150mg/day (around 30mg is albumin)
Microalbuminuria
30-300mg/day
ACR= 3-30mg/mmol
Macroalbuminuria
> 300mg/day
ACR= >30mg/mmol
Asymptomatic proteinuria
<3g/day
Nephrotic range proteinuria
> 3g/day
Proteinuria measurement- Urine Dipstick
Trace= 15-30mg/dL 1+= 30-100mg/dL 2+= 100-300mg/dL 3+= 300-1000mg/dL 4+= >1000mg/dL Will show up +ve if protein >300mg/day Convenient and easy Protein excretion not consistent throughout day Only albumin detected False negatives in multiple myeloma (protein component not albumin)
Proteinuria measurement- ACR/PCR
Daily creatinine excretion almost constant 910mmol/day)
Therefore ACR/PCR corrects for changes in urine conc. throughout day
First morning specimen most accurate
Can multiply PCR/ACR x 10 to obtain approx. value for 24hr excretion
Limitations- extremes of muscle mass, collection timing
24 hour urine collection- proteinuria
Gold standard
Impractical + difficult
Figure precise but often not necessary
Different causes of oedema- pathophysiological mechanisms
Increased hydrostatic pressure
Decreased oncotic pressure
Increased capillary permeability
Lymphatic blockage
Oedema- underfill hypothesis
Decrease in intravascular colloid oncotic pressure due to hypoalbuminuria
Leads to intravascular vol. depletions
Results in overactivation RAAS–> salt and water retention
Oedema- overfill hypothesis
Primary mechanism in nephrotic syndrome
Sodium retention is primary event due to increased Na/K ATPase activity in collecting duct
Leads to expansion of intravascular volume that increases hydrostatic pressure to force more fluid into interstitial space
Nephrotic syndrome
Clinical syndrome arising from failure of glomerular filtration barrier to restrict passage of proteins into Bowman’s space
Proteinuria (>3g/day) associated with hypoalbuminuria (<30g/L), generalised oedema, hyperlipidaemia + thrombotic tendency
Nephritic syndrome
Clinical syndrome associated with underlying glomerulonephritis (inflammation of glomerulus)
Haematuria, mild proteinuria, hypertension, impaired renal function, oliguria + mild oedema
Nephrotic syndrome diagnostic criteria
Proteinuria >3g/day
Hypoalbuminuria <30g/L
Generalised oedema
Hypercholesterolaemia
Nephrotic syndrome clinical history
Generalised oedema
Frothy urine
Collateral history- previous history, OTC NSAIDS, fam history renal disease, weight loss etc
Nephrotic syndrome Investigations
Exam- peripheral + sacral oedema, periorbital oedema, ascites, pleural effusions
BP- can be normal, low or raised
Urine dipstick- protein 4+, blood may be + or -
Nephrotic syndrome differential diagnoses
Minimal change disease Focal segmental glomerulosclerosis Membranous nephropathy Amyloidosis Diabetic nephropathy
Minimal change disease- nephrotic syndrome
Most common cause nephrotic syndrome in children
Idiopathic
Secondary to- recent resp. infection, immunisation, NSAIDs, haematological malignancy
Massive oedema- facial + periorbital swelling, ascites, pleural + pericardial effusions
Absence of microscopic haematuria
BP= low/normal
Light microscopy= normal
Electron microscopy= effacement of podocyte end-feet
Treatment= corticosteroids
Focal segmental glomerulosclerosis- nephrotic syndrome
Most common cause in Hispanic + African American adults
Idiopathic
Secondary to- longstanding hypertension, any chronic kidney condition, HIV, heroin, obesity
Microscopic haematuria often present
BP often raised
Light microscopy- segmental sclerosis + hyalinosis
Electron microscopy- effacement of podocyte end-feet
Treatment- immunosuppression
Nephrotic syndrome- membranous nephropathy
Most common cause primary nephrotic syndrome in Caucasian adults
Most commonly idiopathic
Secondary to- drugs (gold, NSAIDs, penicillamine), infections (HBV, HCV, syphilis), SLE, solid tumours
Microscopic haematuria common
BP often raised
VTE common
Light microscopy- diffuse capillary + GMB thickening
Immunostaining- positive IgG staining
Electron microscopy- subendothelial deposit humps in GBM
Treatment- immunosuppression
Nephrotic syndrome- amyloidosis
Associated with chronic conditions that predispose amyloid deposition
e.g. AA amyloid in IV drug users
Nephrotic syndrome- diabetic nephropathy
Light microscopy- mesangial expansion, GBM thickening, Kimmelstein-Wilson nodules
Electron microscopy= GBM thickening
Nephrotic syndrome- Treatment of oedema
Restrict salt <2g/day
Fluid restriction <1l/day
Loop diuretics to decrease fluid retention
Nephrotic syndrome- Reduction proteinuria
Will reduce aggravation of tubulointerstitial fibrosis which will reduce progression to functional decline
ACEI or ARB for anti-proteinuria effects
BP <125/70
Protein intake 0.8g/kg/day
Nephrotic syndrome- Anticoagulation
NS risk factor for thrombosis
Anti-coagulate with SC heparin or warfarin for duration
Nephrotic syndrome- Infection
Low IgG predisposes to infection
Treat infection promptly
Vaccinate against pneumococcus
Nephrotic syndrome- Dyslipidaemia
Dietary restrictions
Statins
Nephrotic syndrome- Immunosuppression, minimal change
1st line= corticosteroids
2nd line= CNI
3rd line= cyclophosphamide
4th line= rituximab
Nephrotic syndrome- Immunosuppression, FSGS
1st line= corticosteroid
2nd line= CNI
3rd line= cyclophosphamide
4th line- MMF
Nephrotic syndrome- Membranous
1st line= corticosteroid + calcineurin inhibitor
2nd line= cyclophosphamide
3rd line= MMF
4th line= Rituximab
Nephritic syndrome (Glomerulonephritis) diagnostic criteria
Haematuria (urine dip +++)
Red cell casts on urinary microscopy
Mild proteinuria (<1-1.5g/day)
With progression –> hypertension, oedema, AKI
Glomerulonephritis- immune mediated
IgA nephropathy (berger disease)–> most common cause GN worldwide
Small vessel vasculitis- Wegener’s granulomatosis, microscopic polyangiitis
Systemic lupus
Anti-GBM disease
Cryoglubinaemia
Glomerulonephritis- infections
Viral –> hep B, hep C, HIV
Post-streptococcal
Subacute bacterial endocarditis
Glomerulonephritis malignancy
Myeloma
Lymphoma
Glomerulonephritis- IgA nephropathy
Episodic gross haematuria that occurs concurrently with resp/GI infections
Mesangial proliferation
Young adults
Purpuric skin rash
Arthritis
Abdo pain
Worse prognosis if increased BP, male, proteiuria
Glomerulonephritis- Anti-GBM (Goodpasture’s disease)
Isolated renal and pulmonary effects
Anti-GBM in circulation/kidney
Treat- plasma exchange, steroids, cytotoxics
Glomerulonephritis- Wegener’s (granulomatosis with polyangitis)
Vasculitis rash Sinusitis Epistaxis Haemoptysis Eye redness
Glomerulonephritis- microscopic polyangitis
Vasculitis rash Haemoptysis Eye redness Diarrhoea + abdo pain Neuropathy
Glomerulonephritis- SLE
Butterfly malar rash
Painful + swollen joints
Fever
Chest pain
Glomerulonephritis- Myeloma
Bone pain Fractures Anaemia Repeated infections Easy bleeding
Glomerulonephritis- Post-streptococcal
Occurs around 2 weeks after infection Oedema Headache Oliguria Fever Malaise Nausea
Glomerulonephritis Investigations- bloods
FBC U+Es LFTs CRP Nephritic screen
Rapidly Progressive Glomerulonephritis
Term used to describe rapid loss of renal function (50% GFR decline in 3 months) associated with formation of epithelial crescents in majority of glomeruli
Increased creatinine and decreased GFR secondary to GN
Rapidly Progressive Glomerulonephritis- biopsy
Crescent moon shape consisting of fibrin + plasma proteins (e.g. C3b) with glomerular parietal cells, monocytes, macrophages
Rapidly Progressive Glomerulonephritis- types
Immune complex RPGN
Pauci-Immune RPGN- 80-90% are ANCA positive
Anti-GBM
Rapidly Progressive Glomerulonephritis- treatment
Corticosteroids
Cyclophosphamide
Pulmonary renal syndrome
Pulmonary haemorrhage occurring simultaneously with GN
Dyspnoea, cough, fever, haemoptysis, peripheral oedema, haematuria
Treatment= corticosteroids, cyclophosphamide, plasma exchange
Glomerulonephritis treatment- oedema
Limit salt <5g
Limit fluid <1L
Diuretics (loop)
Glomerulonephritis treatment- proteinuria
ACEI/ARB
Glomerulonephritis treatment- BP
<130/80 Diruretics BB CCBs ACEI/ArB
Glomerulonephritis treatment- immunosuppression
Corticosteroids Cyclophosphamide Calcineurin inhibitors Azathioprine Mycophenoate Rituximab
Factors that indicate poor prognosis with any glomerulonephritis
Heavy proteinuria
Sever hypertension
Significant elevations creatinine